A valuable endobronchial ultrasound scoring system predicting malignant lymph nodes
- PMID: 37664768
- PMCID: PMC10472475
- DOI: 10.5606/tgkdc.dergisi.2023.23568
A valuable endobronchial ultrasound scoring system predicting malignant lymph nodes
Abstract
Background: This study aims to determine the sonographic criteria of lymph nodes to predict malignancy with endobronchial ultrasound.
Methods: A total of 1,987 lymph nodes of 967 patients (666 males, 301 females; mean age: 62.1±11.9 years; range, 21 to 90 years) between May 2016 and July 2020 were retrospectively analyzed. The endobronchial ultrasound images of lymph nodes were evaluated according to the following criteria: size (short axis >1 cm), shape (round or oval), margin (distinct or indistinct), coagulation necrosis sign (present or absent), central hilar structure (present or absent) and echogenicity (homogeneous or heterogeneous). A scoring system was developed for predicting malignancy.
Results: A total of 765 (38.5%) of the lymph nodes were malignant. In the univariate analysis, size >1 cm, round shape, distinct margin, absence of central hilar structure, presence of coagulation necrosis sign, and heterogeneity were significant predictors of malignancy (p<0.001 for all). In the multivariate analysis, the main independent predictors were heterogeneity and presence of coagulation necrosis sign (odds ratio=5.9, 95% confidence interval: 4.2-8.2 vs. odds ratio=3.1 95% confidence interval: 2.2-4.5, respectively). A cut-off value for endobronchial ultrasound score of ≥4 increased the malignancy risk 30 times with a sensitivity of 84.7%, and specificity of 84.5%.
Conclusion: Our study results show that endobronchial ultrasound scoring system with six criteria has a high sensitivity and specificity for predicting malignant lymph nodes.
Keywords: Endobronchial ultrasound; lymph node; malignancy; score..
Copyright © 2023, Turkish Society of Cardiovascular Surgery.
Conflict of interest statement
Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
Figures



Similar articles
-
The utility of sonographic features during endobronchial ultrasound-guided transbronchial needle aspiration for lymph node staging in patients with lung cancer: a standard endobronchial ultrasound image classification system.Chest. 2010 Sep;138(3):641-7. doi: 10.1378/chest.09-2006. Epub 2010 Apr 9. Chest. 2010. PMID: 20382710
-
Identification of Sonographic Features for Predicting Benign Versus Malignant Mediastinal or Hilar Lymph Nodes Using Endobronchial Ultrasound.Oman Med J. 2020 Apr 30;35(2):e112. doi: 10.5001/omj.2020.30. eCollection 2020 Mar. Oman Med J. 2020. PMID: 32405434 Free PMC article.
-
Lymph node characteristics of sarcoidosis with endobronchial ultrasound.Endosc Ultrasound. 2014 Oct;3(4):232-7. doi: 10.4103/2303-9027.144541. Endosc Ultrasound. 2014. PMID: 25485271 Free PMC article.
-
Ultrasonographic characteristics of lymph nodes as predictors of malignancy during endobronchial ultrasound (EBUS): A systematic review.Lung Cancer. 2018 Dec;126:97-105. doi: 10.1016/j.lungcan.2018.10.020. Epub 2018 Oct 30. Lung Cancer. 2018. PMID: 30527199
-
Evaluating the use of elastography in endobronchial ultrasound technique as a diagnostic approach for mesothorax lymphadenopathy.Expert Rev Respir Med. 2019 Dec;13(12):1153-1159. doi: 10.1080/17476348.2019.1677466. Epub 2019 Oct 17. Expert Rev Respir Med. 2019. PMID: 31591914 Review.
Cited by
-
Minimally Invasive Sampling of Mediastinal Lesions.Life (Basel). 2024 Oct 11;14(10):1291. doi: 10.3390/life14101291. Life (Basel). 2024. PMID: 39459591 Free PMC article. Review.
References
-
- Yang B, Li F, Shi W, Liu H, Sun S, Zhang G, et al. Endobronchial ultrasound-guided transbronchial needle biopsy for the diagnosis of intrathoracic lymph node metastases from extrathoracic malignancies: A meta-analysis and systematic review. Respirology. 2014;19:834–841. doi: 10.1111/resp.12335. - DOI - PubMed
-
- Silvestri GA, Gonzalez AV, Jantz MA, Margolis ML, Gould MK, Tanoue LT, et al. Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. e211Se250SChest. 2013;143(5 Suppl) doi: 10.1378/chest.12-2355. - DOI - PubMed
LinkOut - more resources
Full Text Sources